 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, September 1, 2000, 20(17):6721-6727
Nitric Oxide and the Oxytocin System in Pregnancy
Rungrudee Srisawat, Mike Ludwig, Philip M. Bull, Alison J. Douglas, John A. Russell, and Gareth Leng Department of Biomedical Sciences, University of Edinburgh Medical School, Edinburgh EH8 9XD, United Kingdom
We examined the functional role of the nitric oxide (NO)-producing system in magnocellular neurons and how this changes at the end of pregnancy, using a combination of blood sampling and oxytocin radioimmunoassay, electrophysiology, immunocytochemistry for Fos expression, and in situ hybridization histochemistry. In urethane-anesthetized virgin rats, systemic administration of NO synthase (NOS) inhibitors led to a facilitation of oxytocin release evoked by hyperosmotic stimulation. Direct application of the NO donor sodium nitroprusside to the supraoptic nucleus by in vivo microdialysis inhibited the electrical activity of both oxytocin neurons and vasopressin neurons, whereas direct application of an NOS inhibitor increased electrical activity, indicating that endogenous NO acts within the supraoptic nucleus to inhibit neuronal activity. However, during late pregnancy, the influence of endogenous NO is dramatically downregulated, reflected by a reduced expression of neuronal NOS mRNA in these neurons and a loss of efficacy of NOS inhibitors on stimulus-evoked oxytocin release. This downregulation may cause the oxytocin system to become more excitable at term, resulting in the capacity for greater release of oxytocin during parturition.
Key words: supraoptic nucleus; microdialysis; osmotic stimulation; in situ hybridization; Fos expression; hypothalamus
Copyright © 2000 Society for Neuroscience 0270-6474/00/20176721-07$05.00/0
This article has been cited by other articles:
K. Powers-Martin, J. K. Phillip, V. C. Biancardi, and J. E. Stern
Heterogeneous distribution of basal cyclic guanosine monophosphate within distinct neuronal populations in the hypothalamic paraventricular nucleus
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1341 - R1350.
[Abstract] [Full Text] [PDF]
N. F. Rossi and W. H. Beierwaltes
Nitric oxide modulation of ETB receptor-induced vasopressin release by rat and mouse hypothalamo-neurohypophyseal explants
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1208 - R1215.
[Abstract] [Full Text] [PDF]
T. Gonzalez-Hernandez, D. Afonso-Oramas, I. Cruz-Muros, P. Barroso-Chinea, P. Abreu, M. del Mar Perez-Delgado, N. Rancel-Torres, and M. del Carmen Gonzalez
Interleukin-6 and Nitric Oxide Synthase Expression in the Vasopressin and Corticotrophin-releasing Factor Systems of the Rat Hypothalamus
J. Histochem. Cytochem., April 1, 2006; 54(4): 427 - 441.
[Abstract] [Full Text] [PDF]
N. Sabatier and G. Leng
Presynaptic actions of endocannabinoids mediate {alpha}-MSH-induced inhibition of oxytocin cells
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R577 - R584.
[Abstract] [Full Text] [PDF]
J. E Stern and W. Zhang
Cellular sources, targets and actions of constitutive nitric oxide in the magnocellular neurosecretory system of the rat
J. Physiol., February 1, 2005; 562(3): 725 - 744.
[Abstract] [Full Text] [PDF]
N. Sabatier, C. H. Brown, M. Ludwig, and G. Leng
Phasic spike patterning in rat supraoptic neurones in vivo and in vitro
J. Physiol., July 1, 2004; 558(1): 161 - 180.
[Abstract] [Full Text] [PDF]
J. E. Stern and M. Ludwig
NO inhibits supraoptic oxytocin and vasopressin neurons via activation of GABAergic synaptic inputs
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1815 - R1822.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|